Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorBAUSSARD, Louise
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPROUST-LIMA, Cecile
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPHILIPPS, Viviane
dc.contributor.authorPORTALES, Fabienne
dc.contributor.authorYCHOU, Marc
dc.contributor.authorMAZARD, Thibault
dc.contributor.authorCOUSSON-GELIE, Florence
dc.date.accessioned2021-07-15T09:10:15Z
dc.date.available2021-07-15T09:10:15Z
dc.date.issued2021-06-20
dc.identifier.issn0885-3924en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/109246
dc.description.abstractEnOBJECTIVE: This longitudinal prospective and observational study was designed to identify fatigue trajectories during a 6-month period of chemotherapy in patients with metastatic colorectal cancer, and examine the psychosocial factors predicting these trajectories. Associations between fatigue and survival were also investigated. METHODS: A total of 169 patients (M(age)=64.36 years, SD=10.5) reported their fatigue levels every 2 weeks for 6 months. Psychological variables (anxiety, depression, internal control, and coping) were assessed at baseline. A Growth Mixture Model was used to identify latent trajectories of fatigue, and a multinomial logistic regression tested covariate predictors of patients' trajectories. RESULTS: Four clinically distinct fatigue trajectories were identified: intense fatigue (6.51%), moderate fatigue (48.52%), no fatigue (33%), and increasing fatigue (11.83%). Fatigue severity was directly associated with overall survival. High depression levels were associated with fatigue severity over time for intense (OR=1.80 [1.32-2.47]) and for moderate (OR=1.58 [1.25-2.00]) fatigue, compared to patients reporting no fatigue. Patients who did not report fatigue were better adjusted, and had more resources, such as better internal control over the disease and less emotion-focused coping (guilt and avoidance), than those who reported intense (OR(control)=0.77 [0.65-0.92]) or moderate (OR(control)=0.89 [0.79-0.99] and OR(coping)=1.13 [1.02-1.24]) fatigue. CONCLUSIONS: Fatigue trajectories differed considerably across patients with metastatic colorectal cancer. This first longitudinal study on colorectal cancer patients involving transactional variables suggests that psychosocial interventions should target these specific outcomes, in order to help patients manage their fatigue.
dc.language.isoENen_US
dc.subject.enCancer
dc.subject.enFatigue
dc.subject.enTrajectories
dc.subject.enLatent class growth analysis
dc.subject.enDepression
dc.title.enDeterminants of distinct trajectories of fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: 6-month follow-up using Growth Mixture Modeling
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jpainsymman.2021.06.019en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34161813en_US
bordeaux.journalJournal of Pain and Symptom Managementen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03286850
hal.version1
hal.date.transferred2021-07-15T09:11:51Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20Pain%20and%20Symptom%20Management&rft.date=2021-06-20&rft.eissn=0885-3924&rft.issn=0885-3924&rft.au=BAUSSARD,%20Louise&PROUST-LIMA,%20Cecile&PHILIPPS,%20Viviane&PORTALES,%20Fabienne&YCHOU,%20Marc&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée